Who we are

We aim to improve the quality of life for everyone

History

HOME > Who we are > History

’19

  • Progressing SPM™ medical devices registration & sales
  • SPM™ cell regeneration clinical study for specific applications
  • Preparing the first launch of consumer products

’18

  • SPM™ cell regeneration study continued Dr. Ju Hee Lee, Severance Hospital & Chanhwa Kim Ph.D., Korea University

’17

  • Started SPM™ cell regeneration clinical study Dr. Ju Hee Lee, Severance Hospital
  • SPM™ safety and efficacy recommended by Dr. Martin C. Mihm Jr. (Harvard Medical School)
  • SPM™ composition applied for a patent

’16

  • Started in-vivo study, led by Dr. Martin C. Mihm Jr. (Harvard Medical School)
  • Appointed Dr. Martin C. Mihm Jr. (Harvard Medical School) as the Head of Medical Advisory Board

’15

  • In-vitro result validation by Anthony J. Sinskey Ph.D.(Massachusetts Institute of Technology)
  • Appointed Anthony J. Sinskey Ph.D.(Massachusetts Institute of Technology) as the Head of Science Advisory Board
  • SPM™ composition completed

’11

  • BIOCOZ GLOBAL Pte. Ltd. and BIOCOZ GLOBAL Korea Corp. established
  • Confirmed the bio-composition and started cell activator study in Korea ChanhwaKim Ph.D., Korea University

’06

  • Research on umbilical cord stem cell initiated at Singapore National University Hospital in 2006